H-DLGEENFK-OH
Ref. 3D-PP42674
1mg | 202.00 € | ||
10mg | 234.00 € | ||
100mg | 412.00 € |
Product Information
Peptide H-DLGEENFK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-DLGEENFK-OH include the following: Targeting endogenous adduction level of serum albumin by parallel reaction monitoring via standard additions and intact protein measurement: biological dosimetry YS Huang, YM Lin, H Chen, CH Wu, CH Syu - Analytical , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.9b04425 Use of stable isotope dimethyl labeling coupled to selected reaction monitoring to enhance throughput by multiplexing relative quantitation of targeted proteins TT Aye, TY Low , Y Bjorlykke, H Barsnes - Analytical , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac300596r CD44, a Predominant Protein in Methylglyoxal-Induced Secretome of Muscle Cells, is Elevated in Diabetic Plasma S Bai , AH Chaurasiya, R Banarjee , PB Walke - ACS , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsomega.0c01318 Glycation of glucose sensitive lysine residues K36, K438 and K549 of albumin is associated with prediabetes R Rathore, BP Sonwane , MG Jagadeeshaprasad - Journal of , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391919302532 Bioinspired design and oriented synthesis of immunogenic site-specifically penicilloylated peptides N Scornet, S Delarue-Cochin, ME Azoury - Bioconjugate , 2016 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.bioconjchem.6b00393 Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages M Pertyà âska-Marczewska, S Kiriakidis, R Wait, J Beech - Cytokine, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1043466604001875 State of the art for measurement of urine albumin: comparison of routine measurement procedures to isotope dilution tandem mass spectrometry LM Bachmann, G Nilsson, DE Bruns - Clinical , 2014 - academic.oup.comhttps://academic.oup.com/clinchem/article-abstract/60/3/471/5621726 Glycated plasma proteins as more sensitive markers for glycemic control in type 1 diabetes L Zhang, Q Zhang - PROTEOMICS-Clinical Applications, 2020 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201900104 Quantitative cross-linking/mass spectrometry using isotope-labelled cross-linkers L Fischer , ZA Chen , J Rappsilber - Journal of proteomics, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391913001449 A reference system for urinary albumin: current status JC Lieske, O Bondar, WG Miller - Clinical Chemistry and , 2013 - degruyter.comhttps://www.degruyter.com/document/doi/10.1515/cclm-2012-0768/html MSACL 2022 Abstract (s) for Jesse Seegmiller J Seegmiller - msacl.orghttps://www.msacl.org/program/view_abstract_selection.php?id=1750&event=2022 Peptide sequence motif analysis of tandem MS data with the SALSA algorithm DC Liebler , BT Hansen, SW Davey - Analytical , 2002 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/ac0155512 Analysis of Plasma Proteome for a Respiratory Disease Cohort Using SONAR on a SYNAPT XS Mass Spectrometer C Hughes, L Gethings, J Ballantyne, R Plumb - lcms.labrulez.comhttps://lcms.labrulez.com/labrulez-bucket-strapi-h3hsga3/720006598en_d4fab49a0c/720006598en.pdf Elevated Level of Glycated KQTALVELVK Peptide of Albumin Is Associated with the Risk of Diabetic Nephropathy AH Chaurasiya, MR Jaiswal, S Bayatigeri, S Kahar - ACS , 2023 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsomega.3c01219
Chemical properties
Technical inquiry about: 3D-PP42674 H-DLGEENFK-OH
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.